Claudy v. USAA Life Insurance Company

CourtDistrict Court, D. Maryland
DecidedFebruary 27, 2020
Docket8:18-cv-00517
StatusUnknown

This text of Claudy v. USAA Life Insurance Company (Claudy v. USAA Life Insurance Company) is published on Counsel Stack Legal Research, covering District Court, D. Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Claudy v. USAA Life Insurance Company, (D. Md. 2020).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MARYLAND Southern Division

KATHLEEN CLAUDY, *

Plaintiff, * v. Case No.: GJH-18-517 * USAA LIFE INSURANCE COMPANY, * Defendant. * * * * * * * * * * * * * *

MEMORANDUM OPINION

This case involves a dispute concerning benefits under a life insurance policy (the “Policy”) issued by Defendant USAA Life Insurance Company insuring the life of Paul Martin for $1,000,000. ECF No. 2; see ECF No. 43-4. Upon Mr. Martin’s death, Defendant rescinded the Policy based on alleged misrepresentations that Mr. Martin made about his health during the application process, and it declined to pay benefits to the Paul Martin Testamentary Trust (the “Trust”), the primary beneficiary of the Policy. ECF Nos. 43-4, 43-19. Plaintiff Kathleen Claudy, Mr. Martin’s sister, subsequently brought this breach of contract action on behalf of the Trust. ECF No. 2. Pending before the Court are the parties’ cross-motions for summary judgment. ECF Nos. 43, 44. No hearing is necessary. See Loc. R. 105.6 (D. Md. 2016). For the following reasons, Defendant’s Motion for Summary Judgment is granted, and Plaintiff’s Cross-Motion for Summary Judgment is denied. I. BACKGROUND A. Application Mr. Martin applied for the Policy in January 2015 (the “Application”), when he was thirty-eight years old. ECF No. 43-4 at 5; ECF No. 43-5 at 22.1 He applied online, signing each part of the Application electronically and consenting to electronic delivery of future documents.

See ECF No. 43-5. The Application contained two parts. The first part requested basic biographical and administrative information regarding Mr. Martin and the proposed beneficiaries. ECF No. 43-5 at 11–25. Immediately above the signature block for this part of the Application, it stated: I have read the questions and answers in this application. I represent that all statements and answers provided in this application and as part of the application process are true, complete and correctly recorded to the best of my knowledge and belief and will be relied upon by USAA Life Insurance Company to form the basis of any policy which may be issued. I agree that a copy of this application, if approved, will be a part of any policy issued. I understand I may not receive an illustration until the policy is issued.

Id. at 15. The second part of the Application involved completion of the “Examiner’s Report.” Id. at 2–9. The Examiner’s Report first required Mr. Martin to complete a questionnaire regarding his medical history. ECF No. 43-5 at 2–5, 7–8. The relevant evidence concerning Mr. Martin’s medical history shows that he had several visits with medical providers between 2008 and 2015. On April 4, 2008, Mr. Martin had an appointment with Dr. Timothy D. Muir, M.D. See ECF No. 43-14. Mr. Martin’s chief complaint was high blood pressure, and he reported to Dr. Muir that he consumed two to three alcoholic

1 Pin cites to documents filed on the Court’s electronic filing system (CM/ECF) refer to the page numbers generated by that system. beverages per day, with a higher intake on weekends, which Dr. Muir’s notes characterized as a decreased alcohol intake. Id. at 2; ECF No. 43-13 at 19. Mr. Martin also reported that he “ha[d] been feeling fine,” but he was not exercising and his diet was “not great.” ECF No. 43-14 at 2; ECF No. 43-13 at 19. Dr. Muir diagnosed Mr. Martin with “hypertension essential,” and the treatment plan included an instruction to “d/c” alcohol.2 ECF No. 43-14 at 3.

Mr. Martin saw Dr. Muir again on June 25, 2010 for a physical examination. ECF No. 43-9. He reported anxiety and weight issues and that he had been “drinking 2 pitchers beer/nig[h]t to manage anxiety and then to sleep” and that he was interested in quitting. Id. at 2. Dr. Muir’s notes indicate that Mr. Martin did not have “[withdrawal symptoms] whe[n] he does not drink, and he actually feels better then,” and that “he feels bad the day after [drinking] and this has kept him from exercising regularly.” Id. The resulting treatment plan involved “see[ing] a therapist re: anxiety, with a goal of d/c [alcohol], at which point he will be able to effectively resume exercise and lose w[eigh]t.” Id. at 6. According to Dr. Muir, this was “at the heart of his overall medical status.” Id. Dr. Muir also ordered an electrocardiogram, see id. at 7–8, which he

later characterized as “normal,” ECF No. 43-13 at 7, and various blood tests, including for lipids and liver function, ECF No. 43-9 at 9–10. After the appointment, on June 30, 2010, Dr. Muir wrote Mr. Martin a prescription for a liver ultrasound that he recommended because Mr. Martin’s liver enzymes were elevated. ECF No. 43-12; ECF No. 43-13 at 32. There is no evidence that Mr. Martin ever completed the liver ultrasound. Mr. Martin also received treatment from Mr. Paul Thorn, PA-C, under the supervision of Dr. Rajshree Thaker, M.D., for hypertension and anxiety in June 2014. ECF No. 43-10; ECF No. 44-5. On June 20, 2014, Mr. Martin told Mr. Thorn that he had suffered from anxiety for most of

2 Dr. Muir’s notes state “d/c etoh.” ECF No. 43-13 at 3. It is undisputed that “etoh” means alcohol. ECF No. 11 at 10. his life, but it had been getting worse over the past year. Id. at 6. He reported that he “used to drink regularly to deal with stress, but he stopped drinking three weeks ago because he realized what he was doing and that he was drinking too much (6–9 beers daily).” Id. At the appointment, Mr. Thorn ordered a basic metabolic panel, complete blood count, hepatic function panel, lipid panel, thyroid stimulating hormone test, and urinalysis. Id. at 5; ECF No. 43-16 at 13. He

recorded in his notes that Mr. Martin had “[p]robable long term anxiety that [he] ha[d] been self- treating with alcohol,” and he prescribed Zoloft and Xanax as part of a treatment plan for anxiety. ECF No. 43-10 at 6. Mr. Martin saw Mr. Thorn again on June 27, 2010 to discuss blood pressure and stress. Id. at 2–5. Mr. Thorn advised Mr. Martin to “continue to abstain from alcohol” as part of a treatment plan for benign hypertension, and to use Xanax “to deal with impending vacation with in[-]laws” as part of a treatment plan for anxiety. Id. at 2. Mr. Thorn’s notes indicate that Mr. Martin was “[a]t risk for relapsing alcohol if he does not have more medicine.” Id. at 3. Finally, Mr. Martin had an appointment with Dr. Thaker on August 11, 2014. ECF No. 43-11. Her notes indicate that he had previously had an abnormal liver function study,

that a hepatic function panel was to be performed the day of the appointment, and that Mr. Martin was “encouraged to decrease alcohol intake.” Id. at 2. Despite this medical history, Mr. Martin provided the following responses to relevant questions in the Examiner’s Report:  Question 5.d. asked, “Has any Insured ever consulted with a health care provider for … disorder of the … liver?” Mr. Martin responded “No.” ECF No. 43-5 at 4.  Question 8.a. asked, “Has any Insured, within the past five years … had an electrocardiogram, X-ray or any other diagnostic test or procedure that was not previously disclosed?” Id. Question 8.b. asked, “Has any Insured, within the past five years … been advised to have any diagnostic test, hospitalization or surgery which was not completed?” Id. Mr. Martin responded “No” to both questions. Id.  Question 11 asked, “Has any Insured been diagnosed or treated for alcohol or drug abuse or been advised by a health care professional to discontinue the use of

alcohol or to seek treatment for drug or alcohol dependency?” Id. Mr. Martin responded “No.”  Question 12 asked, “Has any Insured consulted a health care provider for any reason not previously disclosed?” Id. Mr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Meson v. GATX Technology Services Corp.
507 F.3d 803 (Fourth Circuit, 2007)
Fitzgerald v. Franklin Life Insurance
465 F. Supp. 527 (D. Maryland, 1979)
Pacific Indemnity Co. v. Interstate Fire & Casualty Co.
488 A.2d 486 (Court of Appeals of Maryland, 1985)
Monumental Life Insurance v. Taylor
129 A.2d 103 (Court of Appeals of Maryland, 1964)
Taylor v. NationsBank, N.A.
776 A.2d 645 (Court of Appeals of Maryland, 2001)
Creveling v. Government Employees Insurance
828 A.2d 229 (Court of Appeals of Maryland, 2003)
DeJarnette v. Federal Kemper Insurance
475 A.2d 454 (Court of Appeals of Maryland, 1984)
Insurance Co. of North America v. Coffman
451 A.2d 952 (Court of Special Appeals of Maryland, 1982)
Maryland Casualty Co. v. Blackstone International Ltd.
114 A.3d 676 (Court of Appeals of Maryland, 2015)
Certain Underwriters at Lloyd's, London v. Cohen
785 F.3d 886 (Fourth Circuit, 2015)
Rossignol v. Voorhaar
316 F.3d 516 (Fourth Circuit, 2003)
White Pine Insurance Co. v. Taylor
165 A.3d 624 (Court of Special Appeals of Maryland, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Claudy v. USAA Life Insurance Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/claudy-v-usaa-life-insurance-company-mdd-2020.